Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Single Arm Study to Assess the Immune Effects of Fermented Wheat Germ (FWG) Nutritional Supplementation in Patients With Advanced Malignancies Being Treated With Standard of Care Checkpoint Inhibitor-Based Therapy

NCT05967533 is registered in ClinicalTrials.gov with University of California, Davis as lead sponsor.

NCT NCT05967533
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05967533 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Single Arm Study to Assess the Immune Effects of Fermented Wheat Germ (FWG) Nutritional Supplementation in Patients With Advanced Malignancies Being Treated With Standard of Care Checkpoint Inhibitor-Based Therapy
Lead sponsor
University of California, Davis
Phase
Phase 1
Overall status
Suspended
Start date
June 2, 2023
Completion date
December 31, 2027
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced colorectal carcinoma, advanced lung non-small cell carcinoma, advanced malignant solid neoplasm, advanced melanoma, advanced renal cell carcinoma, advanced triple-negative breast carcinoma, anatomic stage iii breast cancer ajcc v8, anatomic stage iv breast cancer (ajcc) v8, clinical stage iii cutaneous melanoma ajcc v8, clinical stage iv cutaneous melanoma ajcc v8, stage iii colorectal cancer ajcc v8, stage iii lung cancer ajcc v8, stage iii renal cell cancer ajcc v8, stage iv colorectal cancer ajcc v8, stage iv lung cancer ajcc v8, stage iv renal cell cancer ajcc v8